Menü
sharewise zieht um Am Wochenende vom 22./23. August wird das neue sharewise die Hauptseite. Schau es dir jetzt an und sag uns, was dir fehlt. Zum neuen sharewise Was sich ändert
Dieses Wertpapier wird aktuell nicht bei uns gehandelt
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Charles Schwab Corp.

WKN: 874171 / Symbol: SCHW / Name: Charles Schwab / Aktie / Investment Banking & Finanzdienstleistungen / Large Cap /

94,06 €
0,02 %

Charles River Labs Intl

WKN: 939391 / Symbol: CRL / Name: Charles River Lb / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /

249,70 €
1,69 %

Charles Schwab Corp.

WKN: A3DH7S / Name: Charles Schwab Corp. / Aktie / ? /

13,40 €
-4,29 %

Charles & Colvard Ltd.

WKN: A40D1Y / Name: Charles & Colvard Ltd. / Aktie / ? /

1,98 €
-

Charles Schwab Corp.

WKN: A417YL / Name: Charles Schwab Corp. / Aktie / ? /

?
0,00 %

Charles Schwab Corp.

WKN: A286PF / Name: Charles Schwab Corp. / Aktie / ? /

93,14 €
-

Charles Schwab Corp.

WKN: A3KNM1 / Name: Charles Schwab Corp. / Aktie / ? /

99,77 €
-0,05 %

Charles + Colvard Ltd.

WKN: 923940 / Name: Chrles Clvrd / Aktie / Textilien & Bekleidung / Micro Cap /

0,20 €
-6,60 %

Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates
Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates

Charles River Laboratories (CRL) came out with quarterly earnings of $3.02 per share, beating the Zacks Consensus Estimate of $2.72 per share. This compares to earnings of $3.12 per share a year

Has Charles River Laboratories International (CRL) Outpaced Other Medical Stocks This Year?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Has Charles River Laboratories International (CRL) Outpaced Other Medical Stocks This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Charles River Laboratories (CRL) is a stock that can certainly grab the attention

Charles River (CRL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Charles River (CRL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2026, Charles River Laboratories (CRL) reported revenue of $1 billion, down 2.7% over the same period last year. EPS came in at $3.02, compared to $3.12 in the year-ago

Charles River Associates Q2 Earnings Call Highlights
Charles River Associates Q2 Earnings Call Highlights

Key Points

International Markets and Charles River (CRL): A Deep Dive for InvestorsPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
International Markets and Charles River (CRL): A Deep Dive for Investors

Have you looked into how Charles River Laboratories (CRL) performed internationally during the quarter ending June 2026? Considering the widespread global presence of this medical research equipment

Why Is Charles Schwab (SCHW) Up 10% Since Last Earnings Report?
Why Is Charles Schwab (SCHW) Up 10% Since Last Earnings Report?

It has been about a month since the last earnings report for The Charles Schwab Corporation (SCHW). Shares have added about 10% in that time frame, outperforming the S&P 500.

But investors have to

CharlesCek
Zehnmal angemeldet

charlesgbrock
Account aktiviert

CharlesMouch
Account aktiviert

Charlesteala
Account aktiviert

Charlesambig
Account aktiviert